跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ONGLYZA 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ONGLYZA 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
ONGLYZA 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Astrazeneca Ab
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 18, 2024
Approval ID
afab21d00097de01
Company
Astrazeneca Ab
Type
Standard
Approval Details
Approval Id
afab21d00097de01
Drug Cima Aemps Name
ONGLYZA 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
09545006IP
Holder Company Name
Astrazeneca Ab
Marketing Company Name
Elam Pharma Labs S.L.
Holder Company Detail Path
/organization/astrazeneca-ab
Authorization Date
2024-07-18
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Astrazeneca Ab
Company Detail Path
/organization/astrazeneca-ab
Company Information
Pharmaceutical Company Name
ASTRAZENECA AB
Country Name
Spain
City Name
madrid,madrid,country_es
Address
CALLE RAIMUNDO FERNANDEZ VILLAVERDE 63
Website
http://www.astrazeneca.se
Active Ingredients
SAXAGLIPTINA HIDROCLORURO
5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 18, 2024
Approval ID
afab21d00097de01
Type
Standard
Back to CIMA-AEMPS Approvals
